Peucedanocoumarin IICAS# 130464-56-1 |
- Peucedanocoumarin III
Catalog No.:BCN3471
CAS No.:130464-57-2
- (+)-Pteryxin
Catalog No.:BCN3470
CAS No.:13161-75-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 130464-56-1 | SDF | Download SDF |
| PubChem ID | 5434471 | Appearance | Cryst. |
| Formula | C21H22O7 | M.Wt | 386.4 |
| Type of Compound | Coumarins | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(9S,10R)-9-acetyloxy-8,8-dimethyl-2-oxo-9,10-dihydropyrano[2,3-f]chromen-10-yl] (Z)-2-methylbut-2-enoate | ||
| SMILES | CC=C(C)C(=O)OC1C(C(OC2=C1C3=C(C=C2)C=CC(=O)O3)(C)C)OC(=O)C | ||
| Standard InChIKey | LYUZYPKZQDYMEE-JZWAJAMXSA-N | ||
| Standard InChI | InChI=1S/C21H22O7/c1-6-11(2)20(24)27-18-16-14(28-21(4,5)19(18)25-12(3)22)9-7-13-8-10-15(23)26-17(13)16/h6-10,18-19H,1-5H3/b11-6-/t18-,19+/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Peucedanocoumarin II shows only partial relaxation. |
Peucedanocoumarin II Dilution Calculator
Peucedanocoumarin II Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.588 mL | 12.94 mL | 25.8799 mL | 51.7598 mL | 64.6998 mL |
| 5 mM | 0.5176 mL | 2.588 mL | 5.176 mL | 10.352 mL | 12.94 mL |
| 10 mM | 0.2588 mL | 1.294 mL | 2.588 mL | 5.176 mL | 6.47 mL |
| 50 mM | 0.0518 mL | 0.2588 mL | 0.5176 mL | 1.0352 mL | 1.294 mL |
| 100 mM | 0.0259 mL | 0.1294 mL | 0.2588 mL | 0.5176 mL | 0.647 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Peucedanocoumarin I
Catalog No.:BCN3434
CAS No.:130464-55-0
- A-71623
Catalog No.:BCC7354
CAS No.:130408-77-4
- (-)-Catechin gallate(CG)
Catalog No.:BCN5330
CAS No.:130405-40-2
- Paulownin
Catalog No.:BCN6160
CAS No.:13040-46-5
- (RS)-MCPG disodium salt
Catalog No.:BCC7756
CAS No.:1303994-09-3
- CHPG Sodium salt
Catalog No.:BCC7755
CAS No.:1303993-73-8
- DL-AP5 Sodium salt
Catalog No.:BCC7753
CAS No.:1303993-72-7
- 2-Oxokolavenol
Catalog No.:BCN4716
CAS No.:130395-82-3
- Pungiolide A
Catalog No.:BCN8128
CAS No.:130395-54-9
- Decinnamoyltaxagifine
Catalog No.:BCN7329
CAS No.:130394-69-3
- Batimastat (BB-94)
Catalog No.:BCC1223
CAS No.:130370-60-4
- AC 45594
Catalog No.:BCC7544
CAS No.:13037-86-0
- Peucedanocoumarin III
Catalog No.:BCN3471
CAS No.:130464-57-2
- Batimastat sodium salt
Catalog No.:BCC2075
CAS No.:130464-84-5
- A 68930 hydrochloride
Catalog No.:BCC7104
CAS No.:130465-39-3
- ent-11alpha-Hydroxyabieta-8(14),13(15)-dien-16,12alpha-olide
Catalog No.:BCN7330
CAS No.:130466-20-5
- L-655,708
Catalog No.:BCC7023
CAS No.:130477-52-0
- TC-F 2
Catalog No.:BCC6147
CAS No.:1304778-15-1
- SKF 96365 hydrochloride
Catalog No.:BCC6953
CAS No.:130495-35-1
- Cannabisin A
Catalog No.:BCC8138
CAS No.:130508-46-2
- Liriope muscari baily Saponins
Catalog No.:BCN2817
CAS No.:130551-41-6
- Mogroside III
Catalog No.:BCN3167
CAS No.:130567-83-8
- alpha-Terthienylmethanol
Catalog No.:BCN6161
CAS No.:13059-93-3
- Yangambin
Catalog No.:BCN6706
CAS No.:13060-14-5
Relaxant effects of pyranocoumarin compounds isolated from a Chinese medical plant, Bai-Hua Qian-Hu, on isolated rabbit tracheas and pulmonary arteries.[Pubmed:10513627]
Biol Pharm Bull. 1999 Sep;22(9):984-7.
Qian-Hu is a well-known traditional Chinese medicine used for the treatment of respiratory diseases and pulmonary hypertension. We compared the relaxant effects of pyranocoumarin compounds, including (+)-praeruptorin A (Pra-C), Pd-Ia (=(+/-)-praeruptorin A), pteryxin, Peucedanocoumarin II (P-II) and 8-methoxy-psoralen (8-MOP) purified from Bai-Hua Qian-Hu (BQ) in isolated rabbit tracheas and pulmonary arteries. Pra-C, pteryxin and Pd-Ia produced significant relaxant effects in tracheal preparations constricted with 40 mM KCl or 10 microM acetylcholine. The relaxant response to Pra-C, pteryxin or Pd-Ia in preparations constricted with KCl was significantly more potent than that in preparations constricted with acetylcholine. Pra-C, pteryxin or Pd-Ia at a concentration of 30 microM completely relaxed tracheas constricted with 40 mM KCl, whereas P-II at the same concentration showed only partial relaxation. In pulmonary arterial preparations, 8-MOP produced a significant relaxant effect on contractions by 10 microM phenylephrine, without any effect on the contraction by 40 mM KCl. These results suggest that Pd-Ia, pteryxin and Pra-C for their calcium antagonistic action, and 8-MOP for its inhibitory effect on contraction induced by phenylephrine, may be the active principles of BQ for relaxing the smooth muscle of tracheas and pulmonary arteries, and the principle may produce a synergistic effect.
